Verve Therapeutics Inc. (VERV)
NASDAQ: VERV
· Real-Time Price · USD
11.13
0.03 (0.27%)
At close: Jul 24, 2025, 3:59 PM
Verve Therapeutics Stock Forecast
Stock Price Forecast
The 9 analysts with 12-month price forecasts for VERV stock have an median target of 13.25, with a low estimate of 11 and a high estimate of 15. The median target predicts an increase of 19.05% from the current stock price of 11.13.
| Target | Low | Average | Median | High |
|---|---|---|---|---|
| Price | 11 | 13 | 13.25 | 15 |
| Change | -1.17% | 16.80% | 19.05% | 34.77% |
Latest Analyst Insight Report
BMO Capital downgraded Verve Therapeutics to Marke... Unlock content with Pro Subscription
Updated Jun 27, 2025
| Rating | Nov 24 | Feb 25 | Mar 25 | Apr 25 | Jun 25 |
|---|---|---|---|---|---|
| Strong Buy | 1 | 1 | 0 | 3 | 0 |
| Buy | 2 | 0 | 3 | 2 | 0 |
| Hold | 0 | 0 | 0 | 0 | 6 |
| Sell | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 |
| Total | 3 | 1 | 3 | 5 | 6 |
Financial Forecast this Year
Revenue This Year
45.04M
from 32.33M
Increased by 39.3%
Revenue Next Year
16.08M
from 45.04M
Increased by -64.3%
EPS This Year
-2.51
from -2.36
Increased by -6.4%
EPS Next Year
-3.11
from -2.51
Increased by -23.9%